Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Preclinical costs reduced by new human cell culture system from Northern Germany

02.06.2006
The young biotech start up company PRIMACYT has developed a long-term human hepatocyte culture system that may be used as a biosensor for the analysis of drugs, food additives, and chemicals. The entrepreneur team has developed serum-free long-term culture techniques for hepatocytes. Currently, several other companies are validating this culture technique in a multi-center study. The technology is presented on international conferences in San Francisco, USA April 2006 and Linz, Austria June 2006.

The PRIMACYT Cell Culture Technology GmbH has developed serum-free long-term culture techniques for hepatocytes. These technologies allow utilization of human and other mammalian hepatocytes as biosensors for screening purposes, while the hepatocyte specific functions remain intact. On this basis, new innovative products and services will be created to provide pharmaceutical and biotech companies as well as public research institutions with state of the art solutions for their specific demands.


Mikroskopische Aufnahme einer humanen Leberzelle, Primacyt GmbH

The major advantages of this hepatocyte culture system are its robustness and the fact that the hepatocytes remain differentiated and functional for several weeks. Preliminary studies have revealed that repetitive cycles of drug administrations can be applied to the cells. In other words, the hepatocytes may not only be used for one experiment, but instead can be "recycled" and may be used for a second, a third or even a fourth round of experiments. Thereby, the system is designed to reduce the number of animal experiments and to reduce the costs of preclinical studies.

The company is presenting its human hepatocyte culture system HEPAC2 at the annual Experimental Biology meeting in San Francisco, April 1-5, and at the 13th Conference on Alternatives to Animal Testing in Linz, Austria, on June 2-4. "These are a great opportunities for our company to demonstrate the advantages of our culture system to a broad audience" said Dr. Dieter Runge, co-founder and CEO of this young biotech company.

PRIMACYT Cell Culture Technology GmbH has its roots in HeparCell GmbH, originally founded by 4 private individuals in June 2004. In December 2004 HeparCell completed a private financing round led by Genius Venture Capital GmbH. In January 2005 HeparCell started its business at the Technologie- und Gewerbezentrum Schwerin. In October 2005 HeparCell GmbH changed its corporate name to PRIMACYT Cell Culture Technology. PRIMACYT is member of BioCon Valley.

BioCon Valley is the initiative for Life Science and health economy of Mecklenburg-Vorpommern, Germany. As one of the German BioRegions BioCon Valley supports the commercial use of modern life sciences and bio- and medical technologies in the region. BioCon Valley s tasks are networking, managing life science centers (bioincubators), project management and coordination, and life science specific public relation. BioCon Valley collaborates in strategic partnership to the life science initiatives at the Baltic Sea (www.scanbalt.org).

Contact:
PRIMACYT Cell Culture Technology GmbH
Dr. Dieter Runge
Hagenower Straße 73
19061 Schwerin
Germany
Telefon: +49 (0)385 - 3993 600
Telefax: +49 (0)385 - 3993 602
E-mail: info@primacyt.de

Dr. Heinrich Cuypers | idw
Further information:
http://www.primacyt.de
http://www.bcv.org

More articles from Life Sciences:

nachricht What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Simple processing technique could cut cost of organic PV and wearable electronics

06.12.2016 | Materials Sciences

3-D printed kidney phantoms aid nuclear medicine dosing calibration

06.12.2016 | Medical Engineering

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>